![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » OrbusNeich Gains FDA Clearance for Coronary Dilatation Catheters
OrbusNeich Gains FDA Clearance for Coronary Dilatation Catheters
The FDA has awarded marketing clearance to OrbusNeich’s Sapphire PTCA balloon dilatation catheters — the Sapphire II PRO and the Sapphire NC Plus.
The Sapphire II Pro has a tapered tip and an ultra-low profile, allowing entry through tight lesions.
Sapphire NC Plus is indicated for dilatation of in-stent restenosis and post-delivery expansion of balloon expandable coronary stents. — Cynthia Jessup
Upcoming Events
-
21Oct